A Profile of Patients on ASA or NSAIDs Hospitalized with Gastrointestinal Perforations
Author(s) -
James D Bailey,
Robert J. Bailey,
Richard N. Fedorak
Publication year - 1995
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/1995/239138
Subject(s) - medicine , misoprostol , gastrointestinal tract , referral , perforation , nonsteroidal , gastroenterology , asymptomatic , stomach , retrospective cohort study , gastrointestinal bleeding , gastrointestinal perforation , materials science , family medicine , metallurgy , punching , peritonitis , pregnancy , genetics , abortion , biology
BACKGROUND: In a recent clinical trial gastrointestinal tract perforations in patients on nonsteroidal anti-inflammatory drugs (NSAIDs) were found to occur with a frequency of 0.15%, and possibly to be reduced in patients concomitantly using the cytoprotective agent misoprostol
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom